{"success":true,"data":{"pressRelease":{"id":"103397","rtpr_id":"nPn86TGC9a","ticker":"EVGN","exchange":"NASDAQ","all_tickers":["EVGN"],"title":"Evogene Schedules Second Quarter 2026 Financial Results Release","author":"PR Newswire","published_at":"2026-07-30T11:00:03.269Z","article_body":"Evogene Schedules Second Quarter 2026 Financial Results Release\n\nPR Newswire\n\nREHOVOT, Israel, July 30, 2026\n\nZoom conference call scheduled for August 18, 2026, 9:00 AM ET\n\nREHOVOT, Israel, July 30, 2026 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN)\n(TASE: EVGN), a pioneering company in computational chemistry, specializing in\nthe generative design of small molecules for the pharmaceutical and\nagricultural industries, announced today that it will release its financial\nresults for the second quarter 2026, on Tuesday, August 18, 2026.\n\nLater that day, company management will host a conference call to discuss the\nresults at 9:00 AM Eastern Time (4:00 PM Israel time).\n\nTo attend the conference, please register in advance:\n\nhttps://www.veidan-conferencing.com/evogene\n(https://www.veidan-conferencing.com/evogene)\n\nThe entire conference will be available online on the company's website a few\ndays after.\n\nAbout Evogene:\n\nEvogene Ltd. (Nasdaq: EVGN) (TASE: EVGN) is a pioneering company in\ncomputational chemistry, specializing in the generative design of small\nmolecules for drug development and ag chemical products. At the core of its\ntechnology is ChemPass AI™, a proprietary generative AI designed to explore\nvast chemical space and generate novel, highly potent small molecules\noptimized across multiple critical parameters. Built on this powerful\ntechnological foundation, and through strategic partnerships alongside\ninternal product development, Evogene is focused on creating breakthrough\nproducts for the pharmaceutical and agricultural industries, driven by the\nintegration of scientific innovation with real-world industry needs.\n\nFor more information, please visit www.evogene.com (https://www.evogene.com/)\n.\n\nContact\n\nir@evogene.com (mailto:ir@evogene.com)\nTel: +972-8-9311901\n\nLogo - https://mma.prnewswire.com/media/2814604/Evogene_Logo.jpg\n(https://mma.prnewswire.com/media/2814604/Evogene_Logo.jpg)\n\nView original\ncontent:https://www.prnewswire.com/news-releases/evogene-schedules-second-quarter-2026-financial-results-release-302838854.html\n(https://www.prnewswire.com/news-releases/evogene-schedules-second-quarter-2026-financial-results-release-302838854.html)\n\nSOURCE Evogene\n\n\n\nPhoto: \nhttps://mma.prnewswire.com/media/2814604/Evogene_Logo.jpg\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nPn86TGC9a","title":"Evogene Schedules Second Quarter 2026 Financial Results Release","author":"PR Newswire","ticker":"EVGN","created":"2026-07-30T11:00:03.269Z","tickers":["EVGN"],"exchange":"NASDAQ","article_body":"Evogene Schedules Second Quarter 2026 Financial Results Release\n\nPR Newswire\n\nREHOVOT, Israel, July 30, 2026\n\nZoom conference call scheduled for August 18, 2026, 9:00 AM ET\n\nREHOVOT, Israel, July 30, 2026 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN)\n(TASE: EVGN), a pioneering company in computational chemistry, specializing in\nthe generative design of small molecules for the pharmaceutical and\nagricultural industries, announced today that it will release its financial\nresults for the second quarter 2026, on Tuesday, August 18, 2026.\n\nLater that day, company management will host a conference call to discuss the\nresults at 9:00 AM Eastern Time (4:00 PM Israel time).\n\nTo attend the conference, please register in advance:\n\nhttps://www.veidan-conferencing.com/evogene\n(https://www.veidan-conferencing.com/evogene)\n\nThe entire conference will be available online on the company's website a few\ndays after.\n\nAbout Evogene:\n\nEvogene Ltd. (Nasdaq: EVGN) (TASE: EVGN) is a pioneering company in\ncomputational chemistry, specializing in the generative design of small\nmolecules for drug development and ag chemical products. At the core of its\ntechnology is ChemPass AI™, a proprietary generative AI designed to explore\nvast chemical space and generate novel, highly potent small molecules\noptimized across multiple critical parameters. Built on this powerful\ntechnological foundation, and through strategic partnerships alongside\ninternal product development, Evogene is focused on creating breakthrough\nproducts for the pharmaceutical and agricultural industries, driven by the\nintegration of scientific innovation with real-world industry needs.\n\nFor more information, please visit www.evogene.com (https://www.evogene.com/)\n.\n\nContact\n\nir@evogene.com (mailto:ir@evogene.com)\nTel: +972-8-9311901\n\nLogo - https://mma.prnewswire.com/media/2814604/Evogene_Logo.jpg\n(https://mma.prnewswire.com/media/2814604/Evogene_Logo.jpg)\n\nView original\ncontent:https://www.prnewswire.com/news-releases/evogene-schedules-second-quarter-2026-financial-results-release-302838854.html\n(https://www.prnewswire.com/news-releases/evogene-schedules-second-quarter-2026-financial-results-release-302838854.html)\n\nSOURCE Evogene\n\n\n\nPhoto: \nhttps://mma.prnewswire.com/media/2814604/Evogene_Logo.jpg\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved."},"type":"article","timestamp":"2026-07-30T11:00:05.538582463Z","server_sent_at_ms":1785409205538},"received_at":"2026-07-30T11:00:05.592Z","source_url":"https://www.prnewswire.com/news-releases/evogene-schedules-second-quarter-2026-financial-results-release-302838854.html"},"analysis":{"id":"92413","press_release_id":"103397","analysis_json":{"industry":{"label":"Biotechnology","sector":"Health Care"},"redFlags":[],"eventType":"other","narrative":"Evogene Ltd. announced that it will release its financial results for the second quarter of 2026 on Tuesday, August 18, 2026.\n\nManagement is scheduled to host a conference call later that day at 9:00 AM Eastern Time to discuss the quarterly performance.\n\nInvestors must register in advance to attend the call, and a webcast replay will be made available on the company's website shortly after the event.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Routine earnings scheduling announcement."},"keyFigures":null,"quotedText":"","namedEntities":{"people":[],"products":["ChemPass AI™"],"companies":[{"name":"Evogene Ltd.","ticker":"EVGN"}],"dollarAmounts":[]},"materialImpact":{"score":1,"reasoning":"Routine administrative announcement regarding the scheduling of a financial results release and conference call. No material financial or operational data was disclosed."},"tickerRelevance":{"others":[{"ticker":"EVGN","relevance":"cross-listing (TASE)"}],"primary":"EVGN"},"globalImportance":10,"audienceRelevance":15,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"small-cap","eventGravity":"earnings-schedule"}},"event_type":"other","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"Evogene Ltd. announced that it will release its financial results for the second quarter of 2026 on Tuesday, August 18, 2026.\n\nManagement is scheduled to host a conference call later that day at 9:00 AM Eastern Time to discuss the quarterly performance.\n\nInvestors must register in advance to attend the call, and a webcast replay will be made available on the company's website shortly after the event.","key_figures":null,"named_entities":{"people":[],"products":["ChemPass AI™"],"companies":[{"name":"Evogene Ltd.","ticker":"EVGN"}],"dollarAmounts":[]},"model_name":"glm-4.7","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-07-30T13:42:26.502Z","global_importance":10,"audience_relevance":15,"importance_components":{"tickerTier":"small-cap","eventGravity":"earnings-schedule"}},"durationMs":null,"modelName":"glm-4.7"}}